Search Results - "Navalón, Francisco García"

Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis by Cobo Dols, Manuel, Beato Zambrano, Carmen, Cabezón Gutiérrez, Luis, Chicas Sett, Rodolfo, Blancas López-Barajas, María Isabel, García Navalón, Francisco, Fírvida Pérez, José Luis, Serrano Bermúdez, Gala, Togores Torres, Pilar, Delgado Mingorance, Ignacio, Giraldo Marín, Alexandra, Librán Oriol, Anna, Paredes Lario, Alfredo, Sánchez Mauriño, Pedro, Higuera Gómez, Oliver, Moreno Muñoz, Diana, Jiménez López, Antonio Javier, Huerta González, Ibone, Sanz Yagüe, Almudena, Soler López, Begoña

“…Opioid-induced constipation (OIC) can affect up to 63% of all patients with cancer. The objectives of this study were to assess quality of life as well as…”
Get more information

A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia by Fonseca, Paula Jiménez, Carmona-Bayonas, Alberto, García, Ignacio Matos, Marcos, Rosana, Castañón, Eduardo, Antonio, Maite, Font, Carme, Biosca, Mercè, Blasco, Ana, Lozano, Rebeca, Ramchandani, Avinash, Beato, Carmen, de Castro, Eva Martínez, Espinosa, Javier, Martínez-García, Jerónimo, Ghanem, Ismael, Cubero, Jorge Hernando, Manrique, Isabel Aragón, Navalón, Francisco García, Sevillano, Elena, Manzano, Aránzazu, Virizuela, Juan, Garrido, Marcelo, Mondéjar, Rebeca, Arcusa, María Ángeles, Bonilla, Yaiza, Pérez, Quionia, Gallardo, Elena, del Carmen Soriano, Maria, Cardona, Mercè, Lasheras, Fernando Sánchez, Cruz, Juan Jesús, Ayala, Francisco

“…Background: We sought to develop and externally validate a nomogram and web-based calculator to individually predict the development of serious complications…”
Get full text

Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice by Fernández-Montes, Ana, de Velasco, Guillermo, Aguín, Santiago, Farriols, Cristina, Guirado-Risueño, María, Jerviz-Guía, Vanessa G., Baeza-Nadal, María Victoria, Chicas-Sett, Rodolfo, Fírvida, José Luis, García-Navalón, Francisco, Martín, Patricia, Perezagua-Marín, Carmen, Rodríguez, Dulce, Santamaría, Joan, Saurí, Tamara, Cobo, Manuel

“…Opinion statement Management of chronic pain is crucial to improve the quality of life of cancer and palliative care patients. Opioid-based treatments used to…”
Get full text

Analysis of the efficacy and safety of naloxegol administered to patients with cancer and opioid-induced constipation with laxative-inadequate response: A real-world 12 months of follow-up study by Dols, Manuel Cobo, Beato, Carmen, Cabezon-Gutierrez, Luis, Chicas Sett, Rodolfo, Blancas, Isabel, García Navalón, Francisco Javier, Fírvida Pérez, José-Luis, Serrano Bermúdez, Gala, Togores, Pilar, Delgado, Ignacio, Giraldo-Marín, Alexandra, Librán-Oriol, Anna, Paredes Lario, Alfredo, Sánchez Mauriño, Pedro, Higuera, Oliver, Moreno, Diana, Jiménez-López, Antonio Javier, Huerta-González, Ibone, Sanz-Yagüe, Almudena, Soler, Begoña

“…Abstract only e24155 Background: Naloxegol is a peripherally acting, µ-opioid receptor antagonist for treatment of opioid-induced constipation (OIC). The main…”
Get full text

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study by Cobo Dols, Manuel, Beato Zambrano, Carmen, Cabezón-Gutiérrez, Luis, Chicas-Sett, Rodolfo, Blancas López-Barajas, María Isabel, García Navalón, Francisco Javier, Fírvida Pérez, José Luis, Serrano Bermúdez, Gala, Togores Torres, Pilar, Delgado Mingorance, Ignacio, Giraldo Marín, Alexandra, Librán Oriol, Anna, Paredes Lario, Alfredo, Sánchez Mauriño, Pedro, Higuera Gómez, Oliver, Moreno Muñoz, Diana, Huerta González, Ibone, Sanz-Yagüe, Almudena, Soler López, Begoña

“…Naloxegol is a peripherally acting µ-opioid receptor antagonist (PAMORA) for treatment of opioid-induced constipation (OIC). The main objective was to analyse…”
Get more information

Oncologist liaison: Satisfaction and symptoms in cancer long survivors by García Navalón, Francisco Javier, Monfort García, Rosa, Cunquero Tomás, Alberto Jacobo, Umanzor Funez, Gerardo Antonio, Palomar Coloma, Virginia, Iranzo, Vega, Blasco, Ana, Camps, Carlos

“…Abstract only 251 Background: Each year, the prevalence of cancer long survivors (CLS) increases; defined as a person who after five years of diagnosis and…”
Get full text

Development and validation of a Clinical Index of Severe Febrile Neutropenia: A prospective multicenter study by Echaburu, Juan Virizuela, Blasco, Ana, Martinez, Jeronimo, Font, Carme, Antonio Rebollo, Maite, Biosca, Merce, Ramchandani, Avinash, Hernando-Cubero, Jorge, Martinez de Castro, Eva, Espinosa, Javier, Beato, Carmen, Aragon Manrique, Isabel, García Navalón, Francisco Javier, Ghanem Canete, Ismael, Sevillano, Elena, Manzano, Aránzazu, Garrido, Marcelo, Castanon, Eduardo, Jiménez-Fonseca, Paula, Carmona Bayonas, Alberto

“…Abstract only…”
Get full text

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry by Valcarcel, Sena, Gallego, Javier, Jimenez-Fonseca, Paula, Diez, Marc, de Castro, Eva Martínez, Hernandez, Raquel, Arrazubi, Virginia, Custodio, Ana, Cano, Juana María, Montes, Ana Fernández, Macias, Ismael, Visa, Laura, Calvo, Aitana, Tocino, Rosario Vidal, Lago, Nieves Martínez, Limón, María Luisa, Granja, Mónica, Gil, Mireia, Pimentel, Paola, Macia-Rivas, Lola, Pérez, Carolina Hernández, Mangas, Montserrat, Carnicero, Alfonso Martín, Cerdà, Paula, Gonzalez, Lucía Gomez, Navalon, Francisco Garcia, Rambla, Mª Dolores Mediano, Richard, Marta Martin, Carmona-Bayonas, Alberto

“…Purpose This study aimed to compare ramucirumab-paclitaxel versus chemotherapy in second-line (2L) advanced gastroesophageal cancer (aGEC) based on HER2 status…”
Get full text

The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy by Gómez Rueda, Ana, Taus, Álvaro, Álvarez Álvarez, Rosa, Bernabé-Caro, Reyes, Chara, Luis, López-Brea, Marta, Vilà, Laia, Sala González, Maria Ángeles, del Barrio Díaz Aldagalán, Anabel, Esteban Herrera, Beatriz, López Castro, Rafael, Álvarez Cabellos, Ruth, Doménech, Marta, Falagan, Sandra, Moreno Vega, Alberto, Aguado, Carlos, Barba, Andrés, Delgado Ureña, Maria Teresa, Isla, Dolores, Bellido Hernández, Lorena, Fírvida Pérez, José Luis, Juan-Vidal, Óscar, Massutí, Bartomeu, Mielgo-Rubio, Xabier, Ortega, Ana Laura, Catot, Silvia, Dómine, Manuel, Escoín-Pérez, Corina, García Navalón, Francisco, Gil-Bazo, Ignacio, Muñoz, Silvia, Rodríguez-Abreu, Delvys, Villatoro Roldán, Rosa María, Alonso-Jáudenes Curbera, Guillermo, León-Mateos, Luis, Padilla, Airam, Paredes Lario, Alfredo, Sánchez-Torres, José Miguel, Garrido, Pilar

“…Objectives The S-REAL study aimed to assess the effectiveness of durvalumab as consolidation therapy after definitive chemoradiotherapy (CRT) in a real-world…”
Get full text

Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON–SEOM registry by Arias-Martinez, Aranzazu, Martínez de Castro, Eva, Gallego, Javier, Arrazubi, Virginia, Custodio, Ana, Fernández Montes, Ana, Diez, Marc, Hernandez, Raquel, Limón, María Luisa, Cano, Juana María, Vidal-Tocino, Rosario, Macias, Ismael, Visa, Laura, Martin Richard, Marta, Sauri, Tamara, Hierro, Cinta, Gil, Mireia, Cerda, Paula, Martínez Moreno, Elia, Martínez Lago, Nieves, Mérida-García, Antonio José, Gómez González, Lucía, García Navalón, Francisco Javier, Ruiz Martín, Maribel, Marín, Gema, López-López, Flora, Ruperez Blanco, Ana Belen, Fernández, Alejandro Francisco, Jimenez-Fonseca, Paula, Carmona-Bayonas, Alberto, Alvarez-Manceñido, Felipe

“…Background The optimal chemotherapy backbone for HER2-negative advanced esophagogastric cancer, either in combination with targeted therapies or as a…”
Get full text

Cuidados generales a pacientes con ventilación mecánica no invasiva by Fenoll Jimenez, José Joaquín, García Navalón, Antonio Francisco, Marchán Beneyto, Alfredo

“…Objetivos: Homogeneizar los criterios de actuación de Enfermería para mejorar la calidad asistencial. Proporcionar una herramienta de trabajo para los…”
Get full text